Location History:
- Nantes Cedex 1, FR (2013)
- Nantes Cedex, FR (2015)
- Nantes, FR (2013 - 2017)
Company Filing History:
5 out of 1,745 
3 out of 141 
2 out of 5,094 
Years Active: 2013-2017
Title: Nathalie Labarriere: Innovator in Melanoma Research
Introduction
Nathalie Labarriere is a prominent inventor based in Nantes, France. She has made significant contributions to the field of melanoma research, particularly through her innovative work on melanoma antigen peptides. With a total of five patents to her name, Labarriere is recognized for her dedication to advancing medical science.
Latest Patents
Among her latest patents is a melanoma antigen peptide that comprises specific amino acid sequences, including SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, and SEQ ID NO: 5, or function-conservative variants thereof. This invention is aimed at the prevention and treatment of melanoma in patients. Another notable patent involves a similar melanoma antigen peptide with sequences SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, and SEQ ID NO: 15, also intended for melanoma prevention and treatment.
Career Highlights
Labarriere has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Nantes. Her career reflects a strong commitment to research and innovation in the medical field, particularly in oncology.
Collaborations
Some of her notable coworkers include Mathilde Bobinet and Anne Rogel, who have collaborated with her on various research projects.
Conclusion
Nathalie Labarriere's contributions to melanoma research through her patents and collaborations highlight her role as an influential inventor in the medical community. Her work continues to pave the way for advancements in the treatment of melanoma.